🎉 M&A multiples are live!
Check it out!

Kenvue Valuation Multiples

Discover revenue and EBITDA valuation multiples for Kenvue and similar public comparables like Live Verdure, Lavipharm, and EZZ Life Science.

Kenvue Overview

About Kenvue

Kenvue is the world’s largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson’s consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women’s health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson’s, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue’s brands are the global leader in their respective segment thanks to their strong brand power.


Founded

2022

HQ

United States of America
Employees

22K+

Website

kenvue.com

Sectors

Health & Beauty

Financials

LTM Revenue $15.4B

LTM EBITDA $3.7B

EV

$51.2B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Kenvue Financials

Kenvue has a last 12-month revenue of $15.4B and a last 12-month EBITDA of $3.7B.

In the most recent fiscal year, Kenvue achieved revenue of $15.5B and an EBITDA of $2.5B.

Kenvue expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Kenvue valuation multiples based on analyst estimates

Kenvue P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $15.4B $15.5B XXX XXX XXX
Gross Profit $8.2B $8.6B XXX XXX XXX
Gross Margin 53% 56% XXX XXX XXX
EBITDA $3.2B $2.5B XXX XXX XXX
EBITDA Margin 21% 16% XXX XXX XXX
Net Profit $1.5B $1.7B XXX XXX XXX
Net Margin 9% 11% XXX XXX XXX
Net Debt $7.8B $6.9B XXX XXX XXX

Financial data powered by Morningstar, Inc.

Kenvue Stock Performance

As of March 14, 2025, Kenvue's stock price is $23.

Kenvue has current market cap of $43.6B, and EV of $51.2B.

See Kenvue trading valuation data

Kenvue Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$51.2B $43.6B XXX XXX XXX XXX $1.14

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Kenvue Valuation Multiples

As of March 14, 2025, Kenvue has market cap of $43.6B and EV of $51.2B.

Kenvue's trades at 3.3x LTM EV/Revenue multiple, and 14.0x LTM EBITDA.

Analysts estimate Kenvue's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Kenvue and 10K+ public comps

Kenvue Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $51.2B XXX XXX XXX
EV/Revenue 3.3x XXX XXX XXX
EV/EBITDA 20.8x XXX XXX XXX
P/E 42.3x XXX XXX XXX
P/E/Growth 0.8x XXX XXX XXX
EV/FCF 38.4x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Kenvue Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Kenvue Valuation Multiples

Kenvue's NTM/LTM revenue growth is 0%

Kenvue's revenue per employee for the last fiscal year averaged $0.7M, while opex per employee averaged $0.3M for the same period.

Over next 12 months, Kenvue's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Kenvue's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Kenvue and other 10K+ public comps

Kenvue Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 0% XXX XXX XXX XXX
EBITDA Margin 16% XXX XXX XXX XXX
EBITDA Growth -22% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 16% XXX XXX XXX XXX
Revenue per Employee $0.7M XXX XXX XXX XXX
Opex per Employee $0.3M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 41% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Kenvue Public Comps

See public comps and valuation multiples for Health & Beauty comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Acme United XXX XXX XXX XXX XXX XXX
EZZ Life Science XXX XXX XXX XXX XXX XXX
Live Verdure XXX XXX XXX XXX XXX XXX
Lavipharm XXX XXX XXX XXX XXX XXX
Sarantis Group XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Kenvue M&A and Investment Activity

Kenvue acquired  XXX companies to date.

Last acquisition by Kenvue was  XXXXXXXX, XXXXX XXXXX XXXXXX . Kenvue acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Kenvue

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Kenvue

When was Kenvue founded? Kenvue was founded in 2022.
Where is Kenvue headquartered? Kenvue is headquartered in United States of America.
How many employees does Kenvue have? As of today, Kenvue has 22K+ employees.
Who is the CEO of Kenvue? Kenvue's CEO is Mr. Thibaut Mongon.
Is Kenvue publicy listed? Yes, Kenvue is a public company listed on NYS.
What is the stock symbol of Kenvue? Kenvue trades under KVUE ticker.
When did Kenvue go public? Kenvue went public in 2023.
Who are competitors of Kenvue? Similar companies to Kenvue include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm.
What is the current market cap of Kenvue? Kenvue's current market cap is $43.6B
What is the current revenue of Kenvue? Kenvue's last 12-month revenue is $15.4B.
What is the current EBITDA of Kenvue? Kenvue's last 12-month EBITDA is $3.7B.
What is the current EV/Revenue multiple of Kenvue? Current revenue multiple of Kenvue is 3.3x.
What is the current EV/EBITDA multiple of Kenvue? Current EBITDA multiple of Kenvue is 14.0x.
What is the current revenue growth of Kenvue? Kenvue revenue growth between 2023 and 2024 was 0%.
Is Kenvue profitable? Yes, Kenvue is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.